Showing 621 - 640 results of 1,766 for search '(( i point decrease ) OR ( 10 ((ng decrease) OR (((mean decrease) OR (a decrease)))) ))*', query time: 0.15s Refine Results
  1. 621
  2. 622
  3. 623
  4. 624
  5. 625
  6. 626

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  7. 627
  8. 628
  9. 629

    Anti-Neoplastic Effects of Annonacin against Renal Cell Carcinoma by Munusamy, Shankar

    Published 2016
    “…M annonacin treated vs. 7% of cells in G1 phase in control group. In addition, a dose-dependent decrease in the phosphorylation of p70S6 kinase (a downstream target of mTOR) was observed with annonacin treatment at both 24 and 48 h end-points. …”
    Get full text
    Get full text
  10. 630

    EPIDEMIOLOGY OF CHLAMYDIA TRACHOMATIS IN LATIN AMERICA AND THE CARIBBEAN: SYSTEMATIC REVIEW, META-ANALYSES, AND META-REGRESSIONS by ABU-EL-RUZ, RASHA

    Published 2022
    “…We conducted random-effects meta-regressions to identify sources of heterogeneity and possible predictors of high prevalence. Results: The pooled-mean urogenital CT prevalence was 8.2% (95% CI: 7.5-9.1) for general populations, 14.0% (95%CI: 12.7-15.4) for female sex workers, 10.8% (95% CI: 8.4-13.4) for men who have sex with men, male sex workers, and transgenders, 16.1% (95% CI: 12.6-19.8) for symptomatic women, 25.4 (95% CI: 18.6-38.5) for symptomatic men, 9.7% (95%CI: 6.1-14) for HIV-positive individuals and individuals in HIV-discordant couples, and 11.9% (95 CI: 8.5-15.8) for STI clinic attendees. …”
    Get full text
  11. 631
  12. 632
  13. 633
  14. 634
  15. 635

    Blue photobiomodulation LED therapy impacts SARS-CoV-2 by limiting its replication in Vero cells by Zupin, L.

    Published 2021
    “…It was previously shown, in in vitro models of infections, that the LED blue light is able to decrease the viral load of HSV-1 and ZIKV. In our study, LED photobiomodulation therapy (PBMT) at blue wavelengths (450, 454 and 470 nm) was tested in an in vitro model of SARS-CoV-2 infection, employing three experimental settings: SARS-CoV-2 was irradiated and then transferred to cells; already infected cells were irradiated; cells were irradiated prior to infection. …”
    Get full text
    Get full text
    Get full text
  16. 636
  17. 637
  18. 638
  19. 639

    Foamed phase change materials based on recycled polyethylene/paraffin wax blends by Sobolčiak, Patrik

    Published 2021
    “…A stability of samples during 10 heating/cooling cycles was demonstrated. …”
    Get full text
    Get full text
  20. 640